Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
GEN vs CHKP vs PANW vs FTNT vs CRWD
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Software - Infrastructure
Software - Infrastructure
GEN vs CHKP vs PANW vs FTNT vs CRWD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $12.23B | $12.05B | $138.16B | $79.89B | $128.13B |
| Revenue (TTM) | $5.00B | $2.76B | $9.89B | $7.11B | $4.81B |
| Net Income (TTM) | $973M | $1.06B | $1.28B | $1.95B | $-183M |
| Gross Margin | 78.5% | 85.0% | 73.5% | 80.7% | 74.9% |
| Operating Margin | 42.4% | 29.8% | 14.4% | 31.1% | -5.4% |
| Forward P/E | 7.9x | 11.1x | 53.3x | 36.3x | 103.9x |
| Total Debt | $8.20B | $1.97B | $338M | $996M | $820M |
| Cash & Equiv. | $411M | $1.80B | $2.27B | $2.50B | $5.23B |
GEN vs CHKP vs PANW vs FTNT vs CRWD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gen Digital Inc. (GEN) | 100 | 88.6 | -11.4% |
| Check Point Softwar… (CHKP) | 100 | 105.4 | +5.4% |
| Palo Alto Networks,… (PANW) | 100 | 501.2 | +401.2% |
| Fortinet, Inc. (FTNT) | 100 | 387.8 | +287.8% |
| CrowdStrike Holding… (CRWD) | 100 | 575.9 | +475.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEN vs CHKP vs PANW vs FTNT vs CRWD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 27.1%, EPS growth 52.4%, 3Y rev CAGR 14.7%
- 27.1% revenue growth vs CHKP's 6.3%
- Lower P/E (7.9x vs 103.9x)
- 2.5% yield; 1-year raise streak; the other 4 pay no meaningful dividend
CHKP is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- beta 0.36
- Lower volatility, beta 0.36, Low D/E 68.4%, current ratio 2.05x
- Beta 0.36, current ratio 2.05x
- 38.4% margin vs CRWD's -3.8%
Among these 5 stocks, PANW doesn't own a clear edge in any measured category.
FTNT ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 15.8% 10Y total return vs CRWD's 7.7%
- PEG 1.09 vs GEN's 2.90
- 19.4% ROA vs CRWD's -1.9%
CRWD is the clearest fit if your priority is momentum.
- +19.7% vs CHKP's -47.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% revenue growth vs CHKP's 6.3% | |
| Value | Lower P/E (7.9x vs 103.9x) | |
| Quality / Margins | 38.4% margin vs CRWD's -3.8% | |
| Stability / Safety | Beta 0.36 vs CRWD's 1.35 | |
| Dividends | 2.5% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +19.7% vs CHKP's -47.7% | |
| Efficiency (ROA) | 19.4% ROA vs CRWD's -1.9% |
GEN vs CHKP vs PANW vs FTNT vs CRWD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEN vs CHKP vs PANW vs FTNT vs CRWD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GEN leads in 1 of 6 categories
FTNT leads 1 • CRWD leads 1 • CHKP leads 0 • PANW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GEN and CHKP each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PANW is the larger business by revenue, generating $9.9B annually — 3.6x CHKP's $2.8B. CHKP is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to CRWD's -3.8%. On growth, GEN holds the edge at +27.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5.0B | $2.8B | $9.9B | $7.1B | $4.8B |
| EBITDAEarnings before interest/tax | $2.5B | $909M | $1.9B | $2.3B | $22M |
| Net IncomeAfter-tax profit | $973M | $1.1B | $1.3B | $2.0B | -$183M |
| Free Cash FlowCash after capex | $1.5B | $1.3B | $4.1B | $2.4B | $1.2B |
| Gross MarginGross profit ÷ Revenue | +78.5% | +85.0% | +73.5% | +80.7% | +74.9% |
| Operating MarginEBIT ÷ Revenue | +42.4% | +29.8% | +14.4% | +31.1% | -5.4% |
| Net MarginNet income ÷ Revenue | +19.5% | +38.4% | +13.0% | +27.5% | -3.8% |
| FCF MarginFCF ÷ Revenue | +29.9% | +47.5% | +41.1% | +34.3% | +25.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.0% | +4.8% | +14.9% | +20.1% | +23.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +5.8% | +57.9% | +28.6% | +140.5% |
Valuation Metrics
GEN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 12.0x trailing earnings, CHKP trades at a 90% valuation discount to PANW's 122.8x P/E. Adjusting for growth (PEG ratio), GEN offers better value at 1.14x vs FTNT's 1.34x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12.2B | $12.0B | $138.2B | $79.9B | $128.1B |
| Enterprise ValueMkt cap + debt − cash | $20.0B | $12.2B | $136.2B | $78.4B | $123.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.86x | 12.01x | 122.83x | 44.43x | -778.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.92x | 11.07x | 53.30x | 36.28x | 103.89x |
| PEG RatioP/E ÷ EPS growth rate | 1.14x | 1.20x | — | 1.34x | — |
| EV / EBITDAEnterprise value multiple | 9.44x | 13.22x | 85.88x | 35.09x | 1031.68x |
| Price / SalesMarket cap ÷ Revenue | 2.45x | 4.42x | 14.98x | 11.75x | 26.63x |
| Price / BookPrice ÷ Book value/share | 4.79x | 4.41x | 17.82x | 65.26x | 29.19x |
| Price / FCFMarket cap ÷ FCF | 8.03x | 9.97x | 39.82x | 35.89x | 97.79x |
Profitability & Efficiency
FTNT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
FTNT delivers a 155.7% return on equity — every $100 of shareholder capital generates $156 in annual profit, vs $-5 for CRWD. PANW carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEN's 3.14x. On the Piotroski fundamental quality scale (0–9), GEN scores 7/9 vs CRWD's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +39.9% | +36.4% | +13.6% | +155.7% | -4.6% |
| ROA (TTM)Return on assets | +6.1% | +15.8% | +5.1% | +19.4% | -1.9% |
| ROICReturn on invested capital | +15.9% | +23.2% | +17.1% | — | -193.7% |
| ROCEReturn on capital employed | +16.6% | +17.2% | +8.9% | +37.7% | -2.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 4 | 7 | 4 |
| Debt / EquityFinancial leverage | 3.14x | 0.68x | 0.04x | 0.81x | 0.18x |
| Net DebtTotal debt minus cash | $7.8B | $172M | -$1.9B | -$1.5B | -$4.4B |
| Cash & Equiv.Liquid assets | $411M | $1.8B | $2.3B | $2.5B | $5.2B |
| Total DebtShort + long-term debt | $8.2B | $2.0B | $338M | $996M | $820M |
| Interest CoverageEBIT ÷ Interest expense | 4.15x | — | 1559.00x | 214.35x | -6.06x |
Total Returns (Dividends Reinvested)
CRWD leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PANW five years ago would be worth $34,443 today (with dividends reinvested), compared to $9,640 for CHKP. Over the past 12 months, CRWD leads with a +19.7% total return vs CHKP's -47.7%. The 3-year compound annual growth rate (CAGR) favors CRWD at 56.3% vs CHKP's -1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -22.1% | -36.2% | +9.6% | +38.6% | +11.5% |
| 1-Year ReturnPast 12 months | -25.7% | -47.7% | +4.5% | +1.2% | +19.7% |
| 3-Year ReturnCumulative with dividends | +27.2% | -5.6% | +105.2% | +63.4% | +281.9% |
| 5-Year ReturnCumulative with dividends | +7.5% | -3.6% | +244.4% | +154.9% | +167.3% |
| 10-Year ReturnCumulative with dividends | +119.3% | +40.1% | +746.7% | +1584.4% | +772.0% |
| CAGR (3Y)Annualised 3-year return | +8.4% | -1.9% | +27.1% | +17.8% | +56.3% |
Risk & Volatility
Evenly matched — CHKP and FTNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHKP is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than CRWD's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FTNT currently trades 96.1% from its 52-week high vs CHKP's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.36x | 1.02x | 1.02x | 1.35x |
| 52-Week HighHighest price in past year | $32.22 | $233.78 | $223.61 | $112.39 | $566.90 |
| 52-Week LowLowest price in past year | $17.78 | $112.23 | $139.57 | $70.12 | $342.72 |
| % of 52W HighCurrent price vs 52-week peak | +62.7% | +49.4% | +87.9% | +96.1% | +89.2% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 30.3 | 61.6 | 64.3 | 61.7 |
| Avg Volume (50D)Average daily shares traded | 6.4M | 1.3M | 7.5M | 5.8M | 3.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GEN as "Buy", CHKP as "Hold", PANW as "Buy", FTNT as "Hold", CRWD as "Buy". Consensus price targets imply 58.5% upside for GEN (target: $32) vs -19.6% for FTNT (target: $87). GEN is the only dividend payer here at 2.50% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $32.00 | $153.94 | $207.85 | $86.81 | $528.24 |
| # AnalystsCovering analysts | 21 | 63 | 86 | 68 | 65 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | — |
| Dividend / ShareAnnual DPS | $0.50 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.2% | +11.6% | 0.0% | +2.9% | 0.0% |
GEN leads in 1 of 6 categories (Valuation Metrics). FTNT leads in 1 (Profitability & Efficiency). 2 tied.
GEN vs CHKP vs PANW vs FTNT vs CRWD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GEN or CHKP or PANW or FTNT or CRWD a better buy right now?
For growth investors, Gen Digital Inc.
(GEN) is the stronger pick with 27. 1% revenue growth year-over-year, versus 6. 3% for Check Point Software Technologies Ltd. (CHKP). Check Point Software Technologies Ltd. (CHKP) offers the better valuation at 12. 0x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Gen Digital Inc. (GEN) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEN or CHKP or PANW or FTNT or CRWD?
On trailing P/E, Check Point Software Technologies Ltd.
(CHKP) is the cheapest at 12. 0x versus Palo Alto Networks, Inc. at 122. 8x. On forward P/E, Gen Digital Inc. is actually cheaper at 7. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fortinet, Inc. wins at 1. 09x versus Gen Digital Inc. 's 2. 90x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — GEN or CHKP or PANW or FTNT or CRWD?
Over the past 5 years, Palo Alto Networks, Inc.
(PANW) delivered a total return of +244. 4%, compared to -3. 6% for Check Point Software Technologies Ltd. (CHKP). Over 10 years, the gap is even starker: FTNT returned +1584% versus CHKP's +40. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEN or CHKP or PANW or FTNT or CRWD?
By beta (market sensitivity over 5 years), Check Point Software Technologies Ltd.
(CHKP) is the lower-risk stock at 0. 36β versus CrowdStrike Holdings, Inc. 's 1. 35β — meaning CRWD is approximately 277% more volatile than CHKP relative to the S&P 500. On balance sheet safety, Palo Alto Networks, Inc. (PANW) carries a lower debt/equity ratio of 4% versus 3% for Gen Digital Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEN or CHKP or PANW or FTNT or CRWD?
By revenue growth (latest reported year), Gen Digital Inc.
(GEN) is pulling ahead at 27. 1% versus 6. 3% for Check Point Software Technologies Ltd. (CHKP). On earnings-per-share growth, the picture is similar: Gen Digital Inc. grew EPS 52. 4% year-over-year, compared to -725. 9% for CrowdStrike Holdings, Inc.. Over a 3-year CAGR, CRWD leads at 29. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEN or CHKP or PANW or FTNT or CRWD?
Check Point Software Technologies Ltd.
(CHKP) is the more profitable company, earning 38. 8% net margin versus -3. 4% for CrowdStrike Holdings, Inc. — meaning it keeps 38. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEN leads at 42. 4% versus -3. 4% for CRWD. At the gross margin level — before operating expenses — CHKP leads at 85. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEN or CHKP or PANW or FTNT or CRWD more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fortinet, Inc. (FTNT) is the more undervalued stock at a PEG of 1. 09x versus Gen Digital Inc. 's 2. 90x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Gen Digital Inc. (GEN) trades at 7. 9x forward P/E versus 103. 9x for CrowdStrike Holdings, Inc. — 96. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEN: 58. 5% to $32. 00.
08Which pays a better dividend — GEN or CHKP or PANW or FTNT or CRWD?
In this comparison, GEN (2.
5% yield) pays a dividend. CHKP, PANW, FTNT, CRWD do not pay a meaningful dividend and should not be held primarily for income.
09Is GEN or CHKP or PANW or FTNT or CRWD better for a retirement portfolio?
For long-horizon retirement investors, Fortinet, Inc.
(FTNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +1584% 10Y return). Both have compounded well over 10 years (FTNT: +1584%, CRWD: +772. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEN and CHKP and PANW and FTNT and CRWD?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEN is a mid-cap high-growth stock; CHKP is a mid-cap deep-value stock; PANW is a mid-cap quality compounder stock; FTNT is a mid-cap quality compounder stock; CRWD is a mid-cap high-growth stock. GEN pays a dividend while CHKP, PANW, FTNT, CRWD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.